Alyeska Investment Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Alyeska Investment Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100,000	Closed	-$21.7M	–	1035
2021 Q1	$21.7M	Buy	+100,000	New	+$18.8M	0.28%	108

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Alyeska Investment Group's GWPH Position: Q2 2021 in Review

Alyeska Investment Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 100,000 shares — an estimated $21.7M sold.

Alyeska Investment Group first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $21.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Alyeska Investment Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Alyeska Investment Group sold 100,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $21.7M.
Alyeska Investment Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Alyeska Investment Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $21.7M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.